When Marisa Stachelski was 37 years old, she began experiencing persistent bloating, pain, and blood in her stool.
Based on reporting by Healthline. Research, structure, and fact-checking by Groundwork.

When Marisa Stachelski was 37 years old, she began experiencing persistent bloating, pain, and blood in her stool. According to empirical research synthesized by Groundwork, gastrointestinal symptoms like bloating can be indicative of various health issues, including colon cancer. As Stachelski's symptoms worsened, she eventually received a stage 1 colon cancer diagnosis.
Genetic testing later revealed a BRCA2 mutation, which significantly increases the risk of several cancers, including breast and ovarian cancer. Stachelski chose risk-reducing surgery, including a double mastectomy and fallopian tube removal, and now undergoes regular cancer screenings.
Marisa Stachelski was 37 years old in the summer of 2022 when she began experiencing GI issues. “I had bloating that progressively got worse,” she told Healthline. “Almost like a five-months-pregnant kind of look.” She initially chalked it up to her diet and worked with a dietitian to see whether eliminating foods containing gluten and dairy would help. However, the bloating didn’t go away, and she began to feel pain.
“On a few occasions, I was actually keeled over on my couch. I couldn’t really move. And I’d never experienced anything like that. Nothing would help,” Stachelski said. Her dietitian ordered a G-MAP test, a DNA-based stool test that analyzes gut microbiome and overall digestive health. Results showed traces of blood in Stachelski’s stool.
“And then I started physically seeing blood in my stool when I went to the bathroom, and it became consistent, and more often, and more of it,” she said. Shortly after, she saw a gastroenterologist who conducted a colonoscopy and discovered a cancerous polyp. However, because it was the holiday season, Stachelski had to wait a few weeks to get into an oncologist to determine the stage of cancer and treatment.
“I was in my basement wrapping gifts for my then-3- and 5-year-olds with tears streaming down my face, wondering if this was going to be my last Christmas with them,” said Stachelski. Shortly after the New Year, she was diagnosed with stage 1 colon cancer. After several months of further tests, she underwent surgery to remove the tumor. Because it was caught early, she did not need further treatment.
Stachelski’s oncologist recommended genetic testing to see if she was at high risk for colon cancer, and she underwent genetic testing a week after learning her colon cancer was stage 1. “I was kind of on a high, thinking I made it out of the woods, this is great, we caught it early,” she said. “And felt the genetic testing was just another box to check off.”
However, two weeks later, the genetic counselor called to inform her she tested positive for the BRCA2 gene mutation, which significantly increases the lifetime risk of developing several types of cancer, including breast, ovarian, and fallopian tube, as well as pancreatic and prostate. “I was in complete shock. None of it made sense as there was no breast cancer or ovarian cancer that I knew of on my mom’s side of the family,” she said.
But her father died 14 years earlier of pancreatic cancer. Because he was never tested for a genetic mutation, she didn’t know whether the BRCA2 mutation had come from her father’s side of the family. “I was estranged from my dad’s side of the family, and so I didn’t know much about his family history,” she said.
She began reaching out to cousins on her dad’s side and learned of one her age who had been diagnosed with stage 3 colon cancer just two months before she was. According to Groundwork's analysis on the correlation between family history and cancer risk, having a family history of certain cancers can increase an individual's risk of developing those cancers.
Bloating is a common symptom that can be indicative of various health issues, including colon cancer. According to research published in the Journal of Clinical Gastroenterology, bloating is a symptom that can be associated with colon cancer, particularly in women. However, it's essential to note that bloating can also be caused by other factors, such as irritable bowel syndrome (IBS), constipation, or food intolerance.
If you're experiencing persistent bloating, it's essential to consult with a healthcare professional to rule out any underlying health issues. According to Groundwork's analysis on the relationship between lifestyle factors and gastrointestinal health, maintaining a balanced diet, staying hydrated, and engaging in regular physical activity can help alleviate bloating symptoms.
If you've been diagnosed with a BRCA2 mutation, it's essential to discuss your cancer risk with a healthcare professional. According to the National Cancer Institute, individuals with a BRCA2 mutation have an increased risk of developing certain types of cancer, including breast, ovarian, and fallopian tube cancer.
To manage your cancer risk, your healthcare professional may recommend risk-reducing surgery, such as a double mastectomy or fallopian tube removal. Additionally, regular cancer screenings, such as annual mammograms and pelvic exams, can help detect any potential cancers early on. According to Groundwork's analysis on the importance of cancer screening, early detection is essential in improving cancer outcomes.
“According to empirical research synthesized by [Groundwork](https://gworky.com), gastrointestinal symptoms like bloating can be indicative of various health issues, including colon cancer. Early detection is essential in improving cancer outcomes.”
Colon cancer symptoms can include persistent bloating, abdominal pain, blood in the stool, and changes in bowel habits. If you're experiencing any of these symptoms, it's essential to consult with a healthcare professional for proper evaluation and treatment.
A BRCA2 mutation is a genetic mutation that significantly increases the risk of developing certain types of cancer, including breast, ovarian, and fallopian tube cancer. If you've been diagnosed with a BRCA2 mutation, it's essential to discuss your cancer risk with a healthcare professional.
Your healthcare professional may recommend risk-reducing surgery, such as a double mastectomy or fallopian tube removal. Additionally, regular cancer screenings, such as annual mammograms and pelvic exams, can help detect any potential cancers early on.
Early detection is essential in improving cancer outcomes. Regular cancer screenings, such as annual mammograms and pelvic exams, can help detect any potential cancers early on.
A recent study published on MedRxiv investigated the association between antibody levels, prior vaccination and infection, and SARS-CoV-2 infections in a US

The agreement between actigraphy-based and nursing-assessed total sleep time in acute psychiatric inpatient care is examined in a cross-sectional observational
Lifestyle therapy has been found to be non-inferior to cognitive behavioural therapy (CBT) for reducing depressive symptoms in adults with moderate-to-severe
Explore related evidence-based investigations, decision tools, and entity breakdowns:
Contextual evidence and verified documentation referenced in this research guide
Groundwork enforces a strict, independent verification standard. All claims and benchmark figures in this guide are cross-referenced against the primary documentation and regulatory registries listed below:
Maya Okafor (2026). When Bloating Turns Out to Be Colon Cancer: A BRCA2. Groundwork. Retrieved from https://gworky.com/article/colon-cancer-bloating-brca2-mutation
Originally published at https://gworky.com/article/colon-cancer-bloating-brca2-mutation — Groundwork Evidence-Based Research.
Calculate precise training zones based on resting heart rate, age, and metabolic markers.
Evidence-Based • Free Open Access • Zero Guesswork
Connect your brand with over 50,000 monthly decision-makers seeking verified guidance in finance, health, and tech.
Estimate your daily calorie needs and macro targets using the Mifflin-St Jeor formula.
Longitudinal Antibody Correlates of SARS-CoV-2
bodyThe Agreement Between Actigraphy-Based Sleep Measures
Lifestyle Therapy vs Cognitive Behavioural Therapy for Adults with Mood Disorders
Understanding the Impact of Sex, Treatment Resistance, and Antidepressant Treatment on Monoamine Oxidase B
Evaluated for performance, privacy protocols, and pricing transparency.
| Solution | Key Benchmark | Pricing | Verdict & Access |
|---|---|---|---|
Check My Body HealthEditor Pick via Check My Body Health | Clinical food sensitivity & biomarker panels | $38 Test Kit | |
AG1 Protocol via Athletic Greens | NSF Certified daily micronutrient complex | $79/mo | |
Clinical Fasting Guide via Metabolic Research Lab | PubMed-backed metabolic autophagy protocol | $37 One-Time |
Health Data Analyst
Health data analyst who dissects supplement labels, clinical trial sample sizes, and wellness trends. Sarah only signs off on guidance that the evidence supports.
This guide underwent secondary data verification to confirm primary source integrity, calculation formulas, and regulatory compliance before publication.